In Brief: Value Health's PsychoPharmaCare
Value Health's PsychoPharmaCare: Mental health and substance abuse firm Value Behavioral Health and PBM ValueRx are launching program to integrate drug and mental health care data. PsychoPharmaCare includes a centralized review system, protocols for prescribing patterns for psychotropic drugs and intervention care management. Patients suffering from depression will be among first targets of the program...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth